Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

Clinical trial NCT04040205 · RECRUITING

Trial details

NCT number: NCT04040205
Sponsor: Medical College of Wisconsin
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chondrosarcoma Osteosarcoma Soft Tissue Sarcoma

Start date: 2019-10-07
Primary completion: 2027-06-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.